Clinical Trial Update: Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating anti-HIV drug regimens and treatment-switching guidelines in HIV-infected children (Phase 2/Phase 3) has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-04-24